Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop

Affiliations

• ¹ Department of Hematology, CHU de Rennes , Rennes, France.
• ² Department of Pathology, Inserm U955, Université Paris-Est, CHU Henri Mondor , Créteil, France.
• ³ Department of Pathology and Immunology, Washington University , St. Louis, MO, USA.
• ⁴ Genentech , South San Francisco, CA, USA.
• ⁵ Department of Clinical Immunology and Internal Medicine, Hospital Kremlin Bicêtre, Université Paris-Sud , Orsay, France.
• ⁶ de Duve Institute, Université Catholique de Louvain , Brussels, Belgium.
• ⁷ Inserm U917, CHU de Rennes , Rennes, France.
• ⁸ Bristol-Myers Squibb , CA, USA.
• ⁹ Stanford School of Medicine , Stanford, CA, USA.
• ¹⁰ Dana-Farber Cancer Institute , Boston, MA, USA.
• ¹¹ Department of Medicine, Stanford School of Medicine , Stanford, CA, USA.
• ¹² Gustave Roussy Cancer Campus , Villejuif, France.
• ¹³ Division of Hematology , Mayo Clinic, Rochester, MN, USA.
• ¹⁴ CHRU de Tours, Université François-Rabelais and CNRS, UMR7292 , Tours, France.
• ¹⁵ Aduro Biotech Europe , Oss, The Netherlands.
• ¹⁶ Clinical Research-Oncology , Merck & Co , Kenilworth, NJ, USA.
• ¹⁷ UCL Cancer Institute, University College of London , London, UK.
• ¹⁸ Department of Hematology, Université Claude Bernard, Hospices Civils de Lyon , INSERM 1052 , Lyon, France.
• ¹⁹ Inserm UMR 1068, Institut Paoli Calmettes, Aix Marseille Université , Marseille, France.